SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lauren A. Beste, Pamela K. Green, George N. Ioannou, Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients, European Journal of Gastroenterology & Hepatology, 2015, 27, 2, 123

    CrossRef

  2. 2
    Vincenzo Boccaccio, Savino Bruno, Optimal management of patients with chronic hepatitis C and comorbidities, Liver International, 2015, 35,
  3. 3
    Alessandro Soria, Silvia Limonta, Sebastiano Leone, Antonio Muscatello, Nicola Squillace, Alessandra Bandera, Andrea Gori, Similar Success Rates but Lower Incidence of Telaprevir-Related Rash in HIV/HCV Coinfected as Compared to HCV-Monoinfected Patients Treated With Triple Anti-HCV Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015, 69, 1, e37

    CrossRef

  4. 4
    Maribel Rodriguez-Torres, Anuj Gaggar, Gong Shen, Brian Kirby, Evguenia Svarovskaia, Diana Brainard, William T. Symonds, John G. McHutchison, Milagros Gonzalez, Jose Rodriguez-Orengo, Sofosbuvir for Chronic Hepatitis C Virus Infection Genotype 1–4 in Patients Coinfected With HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015, 68, 5, 543

    CrossRef

  5. 5
    Moana Gelu-Simeon, Rodolphe Sobesky, Stéphanie Haïm-Boukobza, Marita Ostos, Elina Teicher, Hélène Fontaine, Dominique Salmon-Ceron, Laurence Meyer, Jean-Claude Trinchet, Bernard Paule, Didier Samuel, Maïté Lewin, Jean-Charles Duclos-Vallée, Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?, AIDS, 2014, 28, 10, 1379

    CrossRef

  6. 6
    Kian Bichoupan, Douglas T Dieterich, Pegylated-IFNα2a for HIV/hepatitis C virus coinfected patients: out with the old, in with the new, Expert Opinion on Biological Therapy, 2014, 14, 9, 1369

    CrossRef

  7. 7
    L. Cotte, J. Braun, C. Lascoux-Combe, C. Vincent, M.-A. Valantin, P. Sogni, K. Lacombe, D. Neau, H. Aumaitre, D. Batisse, P. de Truchis, A. Gervais, C. Michelet, P. Morlat, D. Vittecoq, I. Rosa, I. Bertucci, S. Chevaliez, J.-P. Aboulker, J.-M. Molina, H. Aumaitre, D. Batisse, L. Bernard, A. Cheret, L. Cotte, P. de Truchis, P. Dellamonica, S. Dominguez, A. Gervais, P.-M. Girard, F. Lucht, S. Metivier, C. Michelet, J.-M. Molina, P. Morlat, D. Neau, G. P. Pageaux, S. Pol, I. Rosa, E. Rosenthal, D. Vittecoq, M.-A. Valantin, D. Zucman, Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial, Clinical Infectious Diseases, 2014, 59, 12, 1768

    CrossRef

  8. You have free access to this content8
    Valérie Martel-Laferrière, Douglas T. Dieterich, Treating HCV in HIV 2013: on the cusp of change, Liver International, 2014, 34,